Key result
Total intravenous anesthesia enables successful ICD implantation in a child with HCM.
Why the study?
Hypertrophic cardiomyopathy is a genetic myocardial disease causing sudden cardiac death in adolescents and young adults, requiring careful management during ICD placement.
Case Report (n=1)
Total intravenous anesthesia was successfully and safely used for ICD implantation in a pediatric patient with newly diagnosed hypertrophic cardiomyopathy following a cardiac arrest.
May support TIVA feasibility for pediatric ICD implantation in hypertrophic cardiomyopathy; leaves open prospective validation before wider use.
Hypertrophic cardiomyopathy (HCM) is a genetic myocardial disease usually characterized by asymmetric ventricular septal hypertrophy. HCM is an important cause of sudden cardiac death in adolescents and young adults. We are presenting a case report, ten years boy came in emergency with sudden loss of consciousness (witness cardiac arrest). Child was revived after cardiopulmonary resuscitation and send to coronary care unit. Echocardiography findings were suggestive of HCM. There was history of sudden death of her mother and maternal uncle. After stabilization ICD was implanted under total intravenous anesthesia. Post procedure his hospital stay was uneventful.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2018) conducted a case report in Hypertrophic cardiomyopathy (n=1). Total intravenous anesthesia for ICD implantation was evaluated on Post-procedure hospital stay outcome. Total intravenous anesthesia was successfully used for ICD implantation in a 10-year-old boy with newly diagnosed hypertrophic cardiomyopathy and witnessed cardiac arrest, with an uneventful recovery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: